Pemetrexed‐carboplatin salvage therapy in advanced thyroid cancers
This case series reinforces prior published phase I clinical trial data and shows that pemetrexed can have potent efficacy in the treatment of the most advanced thyroid cancers.
Authors
- Mabel M. Ryder (ORCID: https://orcid.org/0000-0002-0520-6505)
- Keith C. Bible (ORCID: https://orcid.org/0000-0003-3042-5969)
- Ashish V. Chintakuntlawar (ORCID: https://orcid.org/0000-0002-2907-6522)
- Aditi Kumar (ORCID: https://orcid.org/0000-0003-1026-3173)
- Candy S Peskey
- Crystal Hilger
- K. Lee (ORCID: https://orcid.org/0000-0002-6029-2389)
- John C. Morris (ORCID: https://orcid.org/0000-0002-2692-4565)
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Head & Neck
- Published
- 2024-10-27
- DOI
- https://doi.org/10.1002/hed.27940
- Citations
- 5
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.79